Sarcoma. (2013)

• Record Type: Book
• Further Information: Note: Editor, Andrew J. Wagner ; consulting editors, George P. Canellos, H. Franklin Bunn.
• Editors: Wagner, Andrew J
• Contents: Front Cover; Hematology/Oncology Clinics of North America: Sarcoma; Copyright Page; Contributors; Table of Contents; Hematology/OncologyClinics of North America; Preface: Sarcoma; Chapter 1. Gastrointestinal Stromal Tumors: Molecular Markers and Genetic Subtypes; KEYWORDS; KEY POINTS; PATHOLOGY AND DIAGNOSIS; MOLECULAR TYPES OF GIST; RTK-WT GIST; TKI RESISTANCE MECHANISMS; SUMMARY; REFERENCES; Chapter 2. Gastrointestinal Stromal Tumors: Risk Assessment and Adjuvant Therapy; KEYWORDS; KEY POINTS; INTRODUCTION; CURE FROM GIST BY SURGERY; ASSESSMENT OF THE RISK OF GIST RECURRENCE. CLINICAL TRIALS ON ADJUVANT THERAPY IN GISTPREOPERATIVE IMATINIB; THE ROLE OF TUMOR MUTATION ANALYSIS; IMATINIB DOSE; PATIENT FOLLOW-UP DURING AND AFTER ADJUVANT THERAPY; MANAGEMENT OF PATIENTS WHOSE GIST RECURS DURING ADJUVANT THERAPY; FUTURE DEVELOPMENTS; SUMMARY; REFERENCES; Chapter 3. Gastrointestinal Stromal Tumors: Management of Metastatic Disease and Emerging Therapies; KEYWORDS; KEY POINTS; TYROSINE KINASE INHIBITORS; FOOD AND DRUG ADMINISTRATION-APPROVED AGENTS FOR GIST; OTHER THERAPIES EVALUATED FOR THERAPY IN GIST; NON-TKI-TARGETED THERAPIES; AGENTS FOR SPECIAL GIST POPULATIONS. SCOPE OF THE DIAGNOSES DISCUSSEDDEMOGRAPHICS; ANGIOGENESIS VERSUS VASCULOGENESIS AND THE GROWTH OF ENDOTHELIAL TUMORS; CAUSE OF SARCOMAS OF ENDOTHELIAL ORIGIN; GENETIC CHANGES IN ENDOTHELIAL-BASED SARCOMAS; PATHOLOGIC ABNORMALITY OF ENDOTHELIAL TUMORS; PRIMARY THERAPY; TREATMENT OF RECURRENT DISEASE BY DIAGNOSIS; EMERGING THERAPEUTIC OPTIONS; PERSPECTIVE; REFERENCES; Chapter 8. Desmoid Tumors: A Comprehensive Review of the Evolving Biology, Unpredictable Behavior, and Myriad of Management Options; KEYWORDS; KEY POINTS; INTRODUCTION; EPIDEMIOLOGY; PATHOGENESIS. CLINICAL PRESENTATION AND BEHAVIORDIAGNOSIS; PREDISPOSING FACTORS; PROGNOSTIC FACTORS; MANAGEMENT; FUTURE DIRECTIONS; REFERENCES; Chapter 9. Update in Treatment and Targets in Ewing Sarcoma; KEYWORDS; KEY POINTS; INTRODUCTION; MOLECULAR BIOLOGY; INITIAL EVALUATION AND TREATMENT; FUTURE DIRECTIONS; CONCLUDING REMARKS; REFERENCES; Chapter 10. Update on Targets and Novel Treatment Options for High-Grade Osteosarcoma and Chondrosarcoma; KEYWORDS; KEY POINTS; INTRODUCTION; OSTEOSARCOMA; CHONDROSARCOMA; REFERENCES; Chapter 11. Targeted Therapies in Rare Sarcomas: IMT, ASPS, SFT, PEComa, and CCS.
• Publisher Details: Philadelphia : Elsevier
• Publication Date: 2013
• Extent: 1 online resource (xii, pages 872-1090), illustrations
• Subjects: 616.994; Sarcoma; HEALTH & FITNESS -- Diseases -- General; MEDICAL -- Clinical Medicine; MEDICAL -- Diseases; MEDICAL -- Evidence-Based Medicine; MEDICAL -- Internal Medicine; Sarcoma; Electronic books
• Languages: English
• ISBNs: 9780323261012; 0323261019
• Related ISBNs: 9780323261005; 0323261000
• Notes: Note: Includes bibliographical references and index.; Note: Print version record.
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.